GL1X · GenesisL1 explorer

MolNFT v1 · #128097 · protein

Crystal structure of USP7 in complex with the covalent inhibitor, FT827

5NGF: “Crystal structure of USP7 in complex with the covalent inhibitor, FT827”. X-ray diffraction, 1 ligand (8WN). MolNFT v1 #128097 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
5NGF
Type
protein
Length
664 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
UniProt
Q93009
Ligands
8WN

Structure

x-ray diffraction · 1 distinct chain.

ChainMoleculeTypeResiduesSecondary structureUniProt
A, B—protein332—Q93009

Ligands and binding sites

  • 8WN · ~{N}-[2-[4-[4-[(1-methyl-4-oxidanylidene-pyrazolo[3,4-d]pyrimidin-5-yl)methyl]-4-oxidanyl-piperidin-1-yl]carbonylphenyl]phenyl]ethanesulfonamide · ligand · 2 copies · chains A, B
  • EDO · 1,2-ethanediol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 5NGF · Crystal structure of USP7 in complex with the covalent inhibitor, FT827 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.